Search results
NxStage Medical, Inc. is a leading medical technology company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of end-stage renal disease (ESRD) and acute kidney failure. NxStage also has established a small number of dialysis clinics committed to the development of ...
Solo/Independent Home Dialysis. Solo home hemodialysis (HHD) is an innovative option made available in 2017, when the NxStage systems became the first and only hemodialysis machines cleared in the US for HHD without a care partner, during waking hours. That means more patients – even those who live alone and/or don’t have a care partner ...
NxStage System One offers two dialysate sources. The first one is via PureFlow SL, in which a batch of dialysate can be prepared directly at home and warmed up for the treatment. The second one is via dialysate bags as an alternative for home patients.
The NxStage System One delivers hemodialysis therapy in a home setting. The System One consists of the following elements: A small control unit containing a fluid pump and user interface (cycler). A disposable dialyzer and tubing set (cartridge). High-purity fluid (dialysate), prepared by the PureFlow™ SL dialysate
NxStage home hemodialysis products are designed to provide patients with simple, practical options for treatment at home. NxStage HHD Products From hemodialysis machines to cartridges, fluids, and telehealth platform, NxStage's products provide healthcare professionals with complete HHD solutions.
In this section, you’ll find answers to frequently asked questions about home dialysis, including what it is, its benefits, challenges, and available options. If you have additional questions, reach out to your doctor or contact a Patient Consultant at 888-200-6456.
The NxStage systems allow patients to perform hemodialysis treatment in the comfort of their own home, on their own schedule, allowing for more frequent dialysis, and leading to many health benefits. Home hemodialysis patients who treat more frequently report, and studies confirm: Improved lifespan 2; Faster recovery after treatment 3
